Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 21;16(10):e72026.
doi: 10.7759/cureus.72026. eCollection 2024 Oct.

Abdominal Hypertrophy Syndrome: Characteristics and Potential Pathophysiology

Affiliations
Review

Abdominal Hypertrophy Syndrome: Characteristics and Potential Pathophysiology

Igor A Suslin et al. Cureus. .

Abstract

Abdominal hypertrophy syndrome, known as steroid gut, is an uncommon condition affecting bodybuilders and athletes engaged in prolonged usage of growth hormone (GH), insulin, and other anabolic agents. The condition is more commonly known in the professional bodybuilding community as Palumboism, named after David Palumbo, an American bodybuilder. It is characterized by significant enlargement and distension of the abdomen. Precise pathophysiological mechanisms and underlying causes of Palumboism have yet to be fully understood. The primary objective of this study is to conduct a comprehensive literature review of the condition and explore the pathophysiology and possible treatment modalities. We aim to contribute to the existing knowledge of Palumboism and lay the foundation for clinical and surgical management. A literature review was conducted using PubMed and other sources. Specific keywords, such as "palumboism," "bodybuilder gut," "steroid gut," "HGH gut," "insulin gut," "bubble gut," "muscle gut," "abdominal distension," "abdominal organomegaly," "visceral adiposity," "abdominal obesity," "anabolic steroids," and "growth hormone," were employed to retrieve relevant articles. The inclusion criteria focused on studies that investigated the pathophysiology, clinical presentation, and management of Palumboism. A total of 1,222 studies were identified through the search criteria, of which 451 were screened, 33 were assessed for eligibility, and 30 studies were included in the final review. Literature review revealed that no peer-reviewed studies dedicated to Palumboism, underscoring the insufficient research conducted in this area. The available anecdotal data suggest that the prolonged use of high-dose anabolic steroids, particularly human GH and insulin, may contribute to the development of Palumboism. Several potential mechanisms have been proposed, including visceral adiposity, organomegaly, and altered collagen synthesis. Given the dearth of available research on Palumboism, a comprehensive understanding of this condition is yet to be established. Further studies are warranted to elucidate the pathophysiology, establish diagnostic criteria, and explore treatment options for affected individuals.

Keywords: abdominal hypertrophy syndrome; abdominal organomegaly; anabolic steroids; bodybuilder gut; bubble gut; growth hormone; hgh gut; palumboism; steroid gut; visceral adiposity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

References

    1. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Ulshen M, Dowling R, Fuller C, Zimmermann E, Lund P. Gastroenterology. 1993;104:973–980. - PubMed
    1. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. Shulman DI, Hu CS, Duckett G, Lavallee-Grey M. J Pediatr Gastroenterol Nutr. 1992;14:3–11. - PubMed
    1. Truncated and native insulinlike growth factor I enhance mucosal adaptation after jejunoileal resection. Vanderhoof JA, McCusker RH, Clark R, Mohammadpour H, Blackwood DJ, Harty RF, Park JHY. Gastroenterology. 1992;102:1949–1956. - PubMed
    1. Acromegaly. Colao A, Grasso LF, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R. Nat Rev Dis Primers. 2019;5:20. - PubMed
    1. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Petrossians P, Daly AF, Natchev E, et al. Endocr Relat Cancer. 2017;24:505–518. - PMC - PubMed

LinkOut - more resources